Abstract
There is controversy about the role of autoantibodies against desmoglein 1 and 3 (Dsg1 and 3) in the pathogenesis of lichen planus (LP); the authors planned this study to determine the presence of circulating levels of these antibodies in patients with different types of oral LP and to compare that with cutaneous LP and healthy controls. The enzyme-linked immunosorbent assay test was performed on serum samples of 24 cases of erosive oral LP, 29 cases of reticular oral LP, 30 cases of cutaneous LP and 30 healthy controls. The severity of oral LP was evaluated by Reticulation, Erosion and Ulceration scoring system. There were no significant differences in the concentrations of autoantibodies to Dsg1 between the four groups. Autoantibodies to Dsg3 were increased in erosive oral LP compared with healthy controls (p value = 0.005) but no increase was observed between other groups. We did not detect a correlation between the severity of the disease and the levels of anti-Dsg1 and 3 in patients with erosive and reticular types of oral LP. In conclusion, regardless of the increased level of anti-Dsg3 antibody in erosive oral LP, serum concentrations of antibodies were under cut-off values. Moreover, the pathogenic role of anti-Dsg3 antibodies in erosive oral LP is uncertain.
Similar content being viewed by others
Change history
08 August 2017
An erratum to this article has been published.
References
Agarwal R, Saraswat A (2002) Oral lichen planus: an update. Drugs Today (Barc) 38(8):533–547
Chainani-Wu N, Silverman S Jr, Reingold A, Bostrom A, Lozada-Nur F, Weintraub J (2008) Validation of instruments to measure the symptoms and signs of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105(1):51–58. doi:10.1016/j.tripleo.2007.06.022
D’Agosto G, Latini A, Carducci M, Mastroianni A, Vento A, Fei PC (2004) Evaluation of recombinant antigen-based assays for diagnosis of bullous autoimmune diseases. Clin Diagn Lab Immunol 11(4):762–765. doi:10.1128/CDLI.11.4.762-765.2004
Eversole LR (1997) Immunopathogenesis of oral lichen planus and recurrent aphthous stomatitis. Semin Cutan Med Surg 16(4):284–294
Gholizadeh N, Khoini Poorfar H, TaghaviZenouz A, Vatandoost M, Mehdipour M (2015) Comparison of serum autoantibodies to desmogleins I, III in patients with oral lichen planus and healthy controls. Iran J Pathol 10(2):136–140
Harman KE, Seed PT, Gratian MJ, Bhogal BS, Challacombe SJ, Black MM (2001) The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol 144(4):775–780
Herrero-González JE, Parera Amer E, Segura S, Mas Bosch V, Pujol RM, Martínez Escala ME (2016) Epithelial antigenic specificities of circulating autoantibodies in mucosal lichen planus. Int J Dermatol 55(6):634–639. doi:10.1111/ijd.12990
Ingafou M, Lodi G, Olsen I, Porter SR (1997) Oral lichen planus is not associated with IgG circulating antibodies to epithelial antigens. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84(2):175–178
Jamora MJ, Jiao D, Bystryn JC (2003) Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris. J Am Acad Dermatol 48(6):976–977. doi:10.1067/mjd.20030438
Kamiya K, Aoyama Y, Shirafuji Y, Hamada T, Morizane S, Fujii K, Hisata K, Iwatsuki K (2012) Detection of antibodies against the non-calcium-dependent epitopes of desmoglein 3 in pemphigus vulgaris and their pathogenic significance. Br J Dermatol 167(2):252–261. doi:10.1111/j.1365-2133.2012.10929.x
Kato T, Fujimoto N, Uenishi T, Tanaka T (2009) A case of oral lichen planus in a patient with anti-desmoglein antibodies. Skin Res 8:173–176
Kinjyo C, Kaneko T, Korekawa A, Rokunohe A, Aizu T, Matsuzaki Y, Nakano H, Sawamura D (2015) Oral lichen planus with antibodies to desmogleins 1 and 3. J Dermatol 42(1):40–41. doi:10.1111/1346-8138.12661
Kishimoto K, Konno Y, Nakamura K, Kaneko F (2005) A case of oral lichen planus showing antibodies for desmoglein 1 and BP180 NC16a. Rinsho Derma 47:741–744
Lamey PJ, McCartan BE, MacDonald DG, MacKie RM (1995) Basal cell cytoplasmic autoantibodies in oral lichenoid reactions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79(1):44–49
Lin SC, Sun A, Wu YC, Chiang CP (1992) Presence of anti-basal cell antibodies in oral lichen planus. J Am Acad Dermatol 26(6):943–947
Lukac J, Brozović S, Vucicević-Boras V, Mravak-Stipetić M, Malenica B, Kusić Z (2006) Serum autoantibodies to desmogleins 1 and 3 in patients with oral lichen planus. Croat Med J 47(1):53–58
Mutasim DF, Adams BB (2001) Immunofluorescence in dermatology. J Am Acad Dermatol 45(6):803–822. doi:10.1067/mjd.2001.117518 (quiz 822–4)
Muramatsu K, Nishie W, Natsuga K, Fujita Y, Iwata H, Yamada T, Yamashita E, Asaka T, Shimizu H (2016) Two cases of erosive oral lichen planus with autoantibodies to desmoglein 3. J Dermatol 43(11):1350–1353. doi:10.1111/1346-8138.13493
Park HK, Hurwitz S, Woo SB (2012) Oral lichen planus: REU scoring system correlates with pain. Oral Surg Oral Med Oral Pathol Oral Radiol 114(1):75–82. doi:10.1016/j.oooo.2012.02.013
Piboonniyom SO, Treister N, Pitiphat W, Woo SB (2005) Scoring system for monitoring oral lichenoid lesions: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99(6):696–703. doi:10.1016/j.tripleo.2004.07.013
Schiødt M, Holmstrup P, Dabelsteen E, Ullman S (1981) Deposits of immunoglobulins, complement, and fibrinogen in oral lupus erythematosus, lichen planus, and leukoplakia. Oral Surg Oral Med Oral Pathol 51(6):603–608
Shiohara T, Kano Y, Jean L (2012) Lichen planus and lichenoid dermatoses. In: Bolognia JL, Jorizzo JL, Schaffer JV (eds) Dermathology, 3rd edn. Saunders/Elsevier, New York, p 192
Shipman AR, Cooper S, Wojnarowska F (2011) Autoreactivity to bullous pemphigoid 180: is this the link between subepidermal blistering diseases and oral lichen planus? Clin Exp Dermatol 36(3):267–269. doi:10.1111/j.1365-2230.2010.03878.x
Shirakata Y, Amagai M, Hanakawa Y, Nishikawa T, Hashimoto K (1998) Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1. J Invest Dermatol 110(1):76–78. doi:10.1046/j.1523-1747.1998.00085.x
Stanley JR (1989) Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases. J Clin Invest 83(5):1443–1448. doi:10.1172/JCI114036
Sugerman PB, Savage NW, Walsh LJ, Zhao ZZ, Zhou XJ, Khan A, Seymour GJ, Bigby M (2002) The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 13(4):350–365
Acknowledgements
This study was supported by Tehran University of Medical Sciences and Health Services. We thank our colleagues in Razi Hospital, especially Dr. Maryam Daneshpazhooh for comments that improved the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Funding
This study was funded by Tehran University of Medical Sciences.
Ethical statement
The study was approved by the Ethics Committee of Tehran University of Medical Sciences.
Informed consent
Informed consent was obtained from each subject.
Additional information
An erratum to this article is available at https://doi.org/10.1007/s00403-017-1766-8.
Rights and permissions
About this article
Cite this article
Vahide, L., Zahra, H., Forugh, G. et al. Autoantibodies to desmogleins 1 and 3 in patients with lichen planus. Arch Dermatol Res 309, 579–583 (2017). https://doi.org/10.1007/s00403-017-1756-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-017-1756-x